CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,588 enrolled
Drug / intervention
HEMSTOP questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05191251
NCT05191251N/ACompleted

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

Brugmann University Hospital·observational·Posted Jan 13, 2022·Updated Jul 20, 2022

In Brief

An observational study evaluating HEMSTOP questionnaire for Peripartum Period and 2 related conditions. Completed, enrolled 3,588 participants across 1 site.

Detailed Summary

The diagnostic performance of the HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth extraction, Obstetrics, Parents) standardized questionnaire collected during the preoperative anesthesia consultation in order to detect a deficit in hemostasis associated with the risk of hemorrhage in pregnant women will be analyzed. The primary aim of the study is to assess the sensitivity and the specificity of the HEMSTOP questionnaire to identity patients with an abnormal first-line hemostasis test requiring further development by performing second-line hemostasis tests. The second aim of the study is to assess the sensitivity and specificity of the HEMSTOP questionnaire in predicting postpartum hemorrhage.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 13, 2022
Enrollment StartJan 13, 2022
Primary CompletionJun 10, 2022
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.5 years ago

Interventions

HEMSTOP questionnaireother

A HEMSTOP questionnaire is obtained during the anesthesia consultation.